NASDAQ : CV
CapsoVision, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 6.94 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 347.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
CapsoVision, Inc. (CV) reported revenue of 13.89M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Revenue | 13.89M | 13.55M | 11.76M | 9.75M |
| Cost of Revenue | 6.82M | 6.38M | 5.38M | 4.26M |
| Gross Profit | 7.07M | 7.17M | 6.38M | 5.49M |
| Selling, General & Admin | 15.31M | 14.22M | 11.17M | 7.50M |
| Research & Development | 21.55M | 18.31M | 15.12M | 9.33M |
| Operating Expenses | 36.87M | 32.53M | 26.29M | 16.84M |
| Operating Income | -29.80M | -25.36M | -19.92M | -11.35M |
| Interest & Investment Income | 367.00K | 269.00K | 26.00K | 49.00K |
| Other Non Operating Income (Expenses) | -16.00K | -44.00K | 4.00K | 4.00K |
| EBT Excluding Unusual Items | -29.45M | -25.13M | -19.89M | -11.29M |
| Other Unusual Items | -359.00K | -159.00K | ||
| Pretax Income | -29.80M | -25.29M | -19.89M | -11.29M |
| Income Tax Expense | 24.00K | 24.00K | 11.00K | 11.00K |
| Net Income | -29.83M | -25.32M | -19.90M | -11.30M |
| Net Income to Common | -29.83M | -25.32M | -19.90M | -11.30M |
| Shares Outstanding (Basic) | 47.79M | 24.56M | 2.02M | 1.78M |
| Shares Outstanding (Diluted) | 47.79M | 24.56M | 2.02M | 1.78M |
| EPS (Basic) | -0.62 | -1.03 | -9.85 | -6.36 |
| EPS (Diluted) | -0.62 | -1.03 | -9.85 | -6.36 |
| Free Cash Flow | -27.89M | -22.95M | -20.24M | -11.56M |
| Free Cash Flow Per Share | -0.58 | -0.94 | -10.02 | -6.50 |
| Gross Margin | 50.88% | 52.92% | 54.24% | 56.30% |
| Operating Margin | -214.51% | -187.08% | -169.42% | -116.34% |
| Profit Margin | -214.74% | -186.77% | -169.26% | -115.91% |
| Free Cash Flow Margin | -200.77% | -169.35% | -172.20% | -118.49% |
| EBITDA | -29.57M | -25.14M | -19.71M | -11.21M |
| EBITDA Margin | -212.90% | -185.49% | -167.67% | -114.90% |
| D&A For EBITDA | 223.00K | 216.00K | 206.00K | 141.00K |
| EBIT | -29.80M | -25.36M | -19.92M | -11.35M |
| EBIT Margin | -214.51% | -187.08% | -169.42% | -116.34% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Cash & Equivalents | 9.08M | 10.11M | 9.32M | 14.56M |
| Cash & Short-Term Investments | 9.08M | 10.11M | 9.32M | 14.56M |
| Receivables | 2.27M | 2.50M | 2.00M | 1.87M |
| Inventory | 5.30M | 3.29M | 2.98M | 2.41M |
| Prepaid Expenses | 72.00K | 324.00K | 64.00K | |
| Other Current Assets | 567.00K | 448.00K | 485.00K | 371.00K |
| Total Current Assets | 17.28M | 16.67M | 14.85M | 19.20M |
| Property, Plant & Equipment | 1.21M | 1.45M | 1.92M | 2.28M |
| Other Long-Term Assets | 76.00K | 41.00K | 41.00K | 42.00K |
| Total Assets | 18.57M | 18.16M | 16.80M | 21.53M |
| Accounts Payable | 475.00K | 1.14M | 749.00K | 361.00K |
| Accrued Expenses | 3.77M | 2.18M | 429.00K | 613.00K |
| Current Portion of Leases | 442.00K | 410.00K | 351.00K | 276.00K |
| Current Unearned Revenue | 140.00K | 177.00K | 132.00K | 96.00K |
| Other Current Liabilities | 330.00K | 519.00K | 140.00K | 161.00K |
| Total Current Liabilities | 5.16M | 4.43M | 1.80M | 1.51M |
| Long-Term Leases | 245.00K | 477.00K | 887.00K | 1.24M |
| Total Liabilities | 5.40M | 4.90M | 2.69M | 2.75M |
| Common Stock | 50.00K | 47.00K | 2.00K | 6.00K |
| Additional Paid-In Capital | 183.29M | 168.88M | 838.00K | 603.00K |
| Retained Earnings | -170.18M | -155.66M | -130.35M | -110.45M |
| Total Common Equity | 13.17M | 13.26M | -129.51M | -109.84M |
| Shareholders' Equity | 13.17M | 13.26M | 14.12M | 18.78M |
| Total Liabilities & Equity | 18.57M | 18.16M | 16.80M | 21.53M |
| Total Debt | 687.00K | 887.00K | 1.24M | 1.51M |
| Net Cash (Debt) | 8.39M | 9.22M | 8.08M | 13.04M |
| Net Cash Per Share | 0.18 | 0.38 | 4.00 | 7.34 |
| Filing Date Shares Outstanding | 50.05M | 49.84M | 2.20M | 1.85M |
| Total Common Shares Outstanding | 50.03M | 46.87M | 2.11M | 1.85M |
| Working Capital | 12.12M | 12.24M | 13.05M | 17.70M |
| Book Value Per Share | 0.26 | 0.28 | -61.38 | -59.25 |
| Tangible Book Value | 13.17M | 13.26M | -129.51M | -109.84M |
| Tangible Book Value Per Share | 0.26 | 0.28 | -61.38 | -59.25 |
| Machinery | 1.09M | 1.03M | 922.00K | 897.00K |
| Leasehold Improvements | 157.00K | 157.00K | 157.00K | 29.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Net Income | -29.83M | -25.32M | -19.90M | -11.30M |
| Depreciation & Amortization | 595.00K | 567.00K | 521.00K | 388.00K |
| Loss (Gain) From Sale of Assets | 1.00K | 1.00K | ||
| Stock-Based Compensation | 1.42M | 826.00K | 156.00K | 43.00K |
| Provision & Write-off of Bad Debts | 11.00K | 8.00K | 4.00K | |
| Other Operating Activities | 31.00K | -142.00K | 103.00K | -93.00K |
| Change in Accounts Receivable | -400.00K | -478.00K | -176.00K | 7.00K |
| Change in Inventory | -1.66M | -358.00K | -434.00K | -673.00K |
| Change in Accounts Payable | -717.00K | 376.00K | 388.00K | 202.00K |
| Change in Unearned Revenue | 43.00K | 45.00K | 36.00K | 22.00K |
| Change in Other Net Operating Assets | 2.70M | 1.60M | -795.00K | 603.00K |
| Operating Cash Flow | -27.82M | -22.86M | -20.09M | -10.80M |
| Capital Expenditures | -68.00K | -90.00K | -153.00K | -754.00K |
| Investing Cash Flow | -68.00K | -90.00K | -153.00K | -754.00K |
| Short-Term Debt Issued | 1.00M | |||
| Total Debt Issued | 1.00M | |||
| Short-Term Debt Repaid | -1.00M | |||
| Total Debt Repaid | -1.00M | -1.00M | ||
| Issuance of Common Stock | 40.71M | 26.79M | 74.00K | 174.00K |
| Other Financing Activities | -3.78M | -3.18M | ||
| Financing Cash Flow | 35.91M | 23.60M | 15.07M | 20.53M |
| Foreign Exchange Rate Adjustments | -11.00K | 143.00K | -70.00K | 37.00K |
| Miscellaneous Cash Flow Adjustments | -2.00K | |||
| Net Cash Flow | 8.01M | 793.00K | -5.24M | 9.01M |
| Free Cash Flow | -27.89M | -22.95M | -20.24M | -11.56M |
| Free Cash Flow Margin | -200.77% | -169.35% | -172.20% | -118.49% |
| Free Cash Flow Per Share | -0.58 | -0.94 | -10.02 | -6.50 |
| Levered Free Cash Flow | -16.28M | -13.01M | -12.59M | |
| Unlevered Free Cash Flow | -16.28M | -13.01M | -12.59M | |
| Cash Interest Paid | 15.00K | 15.00K | ||
| Cash Income Tax Paid | 13.00K | 9.00K | 6.00K | 1.00K |
| Change in Working Capital | -34.00K | 1.19M | -981.00K | 161.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Market Capitalization | 336.82M | 500.75M | ||
| Enterprise Value | 328.43M | 483.95M | ||
| Last Close Price | 6.73 | 10.69 | ||
| PS Ratio | 24.25 | 36.95 | ||
| PB Ratio | 25.57 | 37.76 | ||
| P/TBV Ratio | 25.58 | 37.76 | ||
| EV/Sales Ratio | 23.64 | 35.70 | ||
| Debt / Equity Ratio | 0.05 | 0.07 | 0.09 | 0.08 |
| Net Debt / Equity Ratio | -0.64 | -0.70 | -0.57 | -0.69 |
| Net Debt / EBITDA Ratio | 0.28 | 0.37 | 0.41 | 1.16 |
| Net Debt / FCF Ratio | 0.30 | 0.40 | 0.40 | 1.13 |
| Asset Turnover | 0.99 | 0.78 | 0.61 | |
| Inventory Turnover | 1.58 | 2.04 | 2.00 | |
| Quick Ratio | 2.20 | 2.85 | 6.29 | 10.90 |
| Current Ratio | 3.35 | 3.77 | 8.24 | 12.74 |
| Return on Equity (ROE) | -335.06% | -184.95% | -120.97% | |
| Return on Assets (ROA) | -132.47% | -90.65% | -64.95% | |
| Return on Capital Employed (ROCE) | -222.20% | -184.60% | -132.80% | -56.70% |
| Earnings Yield | -9.27% | -5.05% | ||
| FCF Yield | -8.28% | -4.58% | ||
| Buyback Yield / Dilution | -2,118.22% | -1,115.57% | -13.70% |